RDNT

RadNet, Inc. 10-Q Summary: Quarter Ended March 31, 2010

Business Context and Reporting Period

This filing is a Quarterly Report (Form 10-Q) for RadNet, Inc., covering the three-month period ended March 31, 2010. RadNet operates 183 diagnostic imaging facilities across seven states, primarily in California, Maryland, Florida, Kansas, Delaware, New Jersey, and New York. The company provides services including MRI, CT, PET, nuclear medicine, and mammography. The financial statements consolidate RadNet Management, Inc. and Beverly Radiology Medical Group III (BRMG), a variable interest entity controlled by the company's CEO.

Key Financial Metrics

Note: Total debt includes current and long-term notes payable and obligations under capital leases. Cash equivalents were depleted during the quarter.

Material Changes vs. Prior Period

• Revenue Decline: Net revenue decreased 3.0% year-over-year. On a same-center basis, revenue dropped 7.2%, primarily attributed to procedure cancellations due to severe snow storms on the East Coast in January and February 2010.
• Profitability Compression: Operating income fell 55.6% to $4.4 million. While operating expenses increased slightly (1.7%), the revenue decline and increased severance costs ($132k vs $17k) impacted margins.
• Net Loss Expansion: Net loss attributable to common stockholders increased significantly to $4.1 million from $0.8 million, driven by lower operating income and reduced equity earnings from joint ventures.
• Liquidity Strain: Cash and cash equivalents dropped from $10.1 million at the start of the quarter to $0 by March 31, 2010, due to heavy investing and financing outflows.
• Interest Expense Reduction: Interest expense decreased 23.5% to $10.0 million, largely due to lower LIBOR rates and the absence of amortization charges related to interest rate swap modifications that impacted the prior year.

Guidance, Outlook, and Subsequent Events

The filing does not provide specific numerical guidance for future periods. However, management expressed confidence in generating sufficient cash to meet obligations for the next twelve months through strategic plans.

Significant Subsequent Events (Post-March 31, 2010):

• Debt Refinancing: On April 6, 2010, RadNet completed a $585 million debt refinancing. This included a $285 million senior secured term loan, a $100 million revolving credit facility, and $200 million in senior unsecured notes (10.375% coupon). The company recorded a $9.8 million loss on extinguishment of debt.
• Acquisitions: The company completed the acquisition of Truxtun Medical Group (April 16) and three facilities from Sonix Medical Resources (April 30).
• Regulatory Impact: The filing highlights risks associated with the Patient Protection and Affordable Care Act (PPACA), specifically changes to Medicare reimbursement rates and utilization factors for advanced imaging equipment, which could reduce future revenues.

Investor Verification Checklist

• Liquidity Position: Verify the impact of the April 2010 refinancing on the company's cash position, given the $0 cash balance at quarter-end.
• Debt Covenants: Review the restrictive covenants in the new $585 million credit agreement and indenture, specifically regarding leverage ratios and capital expenditure limits.
• Reimbursement Rates: Assess the potential revenue impact of the PPACA changes to Medicare Physician Fee Schedule utilization rates (increasing from 50% to 75% for high-cost equipment).
• Weather Impact: Confirm if the Q1 revenue decline due to East Coast snow storms was a one-time anomaly or indicative of broader operational vulnerabilities.
• Joint Venture Performance: Monitor the equity earnings from unconsolidated joint ventures, which declined 29% year-over-year.